Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile Evaluación de la indicación, consumo y costos de antifúngicos en un hospital pediátrico de Chile
Artículo

Open/ Download
Access note
Acceso Abierto
Publication date
2018Metadata
Show full item record
Cómo citar
Barraza Olivares, Marlon
Cómo citar
Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile Evaluación de la indicación, consumo y costos de antifúngicos en un hospital pediátrico de Chile
Author
Abstract
© 2018, Sociedad Chilena de Infectologia. All rights reserved. Background: The increase of invasive fungal disease (IFD) in immunocompromised patients has led to the frequent prescription of highly active antifungal drugs but with a high economic cost. Aim: To characterize the use of antifungals drugs, evaluate its prescription and determine consumption and associated costs. Methods: Retrospective descriptive study from January 2015 to April 2016. Audit of prescriptions and review of clinical files. Each prescription was classified according to whether it corresponded to a possible, probable or proven invasive fungal disease (IFD). Consumptions and treatment costs were calculated. Results: 152 antifungal prescriptions were audited in 79 patients. The total cost of antifungal medications was US $ 714,413. 52.1% of the expenditure (US $ 372,319) corresponded to indications in proven IFD, 10.7% (US $ 76,377) probable IFD, 0.8% (US $ 5,638) non-IFI, 12.2% (US $ 87,459) IFD possible and 1.5
Indexation
Artículo de publicación SCOPUS
Identifier
URI: https://repositorio.uchile.cl/handle/2250/167694
DOI: 10.4067/s0716-10182018000400351
ISSN: 07161018
Quote Item
Revista Chilena de Infectologia, Volumen 35, Issue 4, 2018, Pages 351-357
Collections